CAPABILITIES
Pioneering two new capabilities for natural human antibodies
We leverage our platform to engineer epitope specific antibodies, such as agonists, antagonists, conformation-specific or conditional binders; or multibodies, which are multi-specific symmetrical IgG binding to more than one target on the same Fab.
Biolojic’s multibodies will solve key challenges in treating autoimmune diseasesand cancers.
PLATFORM
A Revolutionary New Approach
Using machine learning, we create superior drugs by programming antibodies to become dynamic functional switches that affect biology in new ways.
Biolojic’s AI-designed antibodies provide a precise molecular effect, in the desired micro-environment, at the right time, leading to greater efficacy and lower toxicity, while maintaining impeccable developability, half-life, stability and safety of human antibodies.
CAPABILITIES
Pioneering two new capabilities for natural human antibodies
We leverage our platform to engineer epitope specific antibodies, such as agonists, antagonists, conformation-specific or conditional binders; or multibodies, which are multi-specific symmetrical IgG binding to more than one target on the same Fab.
Biolojic’s multibodies will solve key challenges in treating autoimmune diseasesand cancers.
PLATFORM
A Revolutionary New Approach
Using machine learning, we create superior drugs by programming antibodies to become dynamic functional switches that affect biology in new ways.
Biolojic’s AI-designed antibodies provide a precise molecular effect, in the desired micro-environment, at the right time, leading to greater efficacy and lower toxicity, while maintaining impeccable developability, half-life, stability and safety of human antibodies.
PIPELINE
Bringing novel technology to well-established biology
We’re on a mission to cure disease.
Our pipeline of computationally designed programmable antibodies focuses on autoimmune diseases and immuno-oncology.
We target well-understood, validated biological pathways. We use our technology to design smart antibodies that affect these pathways more precisely and can succeed where traditional drugs have failed.
PIPELINE
Bringing novel technology to well-established biology
We’re on a mission to cure disease.
Our pipeline of computationally designed programmable antibodies focuses on autoimmune diseases and immuno-oncology.
We target well-understood, validated biological pathways. We use our technology to design smart antibodies that affect these pathways more precisely and can succeed where traditional drugs have failed.
